David J. Jacofsky, MD
Chairman of the Board
David J. Jacofsky, MD is an international speaker and respected authority in complex adult joint reconstruction and oncology, and is a leading authority on health care reform strategies. Dr. Jacofsky has extensive background in business management. He is the founder, CEO and Chairman of Healthcare Outcomes Performance Co. (HOPCo) and The CORE Institute®, and its affiliated entities. He is the Chairman of The Board for Cold Plasma Medical Technologies and has been the CEO of multiple successful start-up companies.Read Full Bio
Brian Morfitt is a General Partner with Frazier Healthcare Partners. Since joining the firm in 2003, he has been involved in Frazier’s investments in Bravo Health (acquired by Health Spring) CHG Healthcare Services (acquired by J.W.Childs Associates), Pentec Health (acquired by NEP), Priority Solutions (acquired by Thermo Fisher Scientific), and TridentUSA Health Services (acquired by Formation Capital). He also leads the Growth Buyout team’s debt capital markets activities.
In addition to HOPCo, Mr. Morfitt serves on the boards of Correct Care Solutions, Orthotic Holdings, Leiter’s, Matrix Medical Network, Southside Pharmacy, and the Health Care Private Equity Association.
Bryan Wall, MD
Bryan Wall, MD is HOPCo’s Vice Chairman and Chief of Medical Informatics, overseeing medical records, reviewing and analyzing data, and interfacing with the programming team to support the design and use of health technology. He led customization of HOPCo’s EMR environment, making it more physician-friendly and focused on patient-oriented quality initiatives.Read Full Bio
James Waskovich is the Founder and Managing Partner of Princeton Ventures, a private equity firm that provides capital and expertise to rapidly growing, market-defining businesses in the consumer, healthcare and technology industries.
Mr. Waskovich was previously with ABS Capital Partners, where he worked with several of the firm’s investments including Cyveillance, DrugMax, eFashion Solutions, Emptoris, and RLX Technologies. Prior to that, he was responsible for sourcing and executing investments at Summit Partners. Mr. Waskovich received his B.A. from Washington and Lee University where he was a George Washington Honor Scholar.
In addition to HOPCo, Mr. Waskovich has participated on a number of boards including Double-Take Software, European Wax Center, Massage Envy, and Rosetta Stone.
Jason J. Scalise, MD
Jason Scalise, MD serves as the Vice Chairman for Strategy, and Director of National Physician Integration for HOPCo, playing a leading role in expanding HOPCo’s growing national network into new markets, as well as integrating new physicians into existing markets. Dr. Scalise also leads multiple HOPCo’s efforts to develop and foster new technologies that help the network and its managed practices drive efficiencies and patient value across the spectrum of patient care.Read Full Bio
Lynn Massingale, MD
H. Lynn Massingale, MD, FACEP, is Co-Founder and Chairman of Team Health, a multi-billion-dollar corporation now comprised of 20,000 affiliated clinicians delivering care to 3,300 acute and post-acute facilities and physician groups throughout the United States. Serving as CEO from 1979 to 2009, he executed a record-setting merger of emergency physician groups, while simultaneously presiding over impressive organic growth. TeamHealth’s revenues grew from $70 million dollars in 1995 to $1 billion dollars in 2005. The most recent figures show revenue approaching $4 billion dollars.
During that time, TeamHealth has been called one of “America’s Most Trustworthy Companies” by Forbes Magazine, one of the “World’s Most Admired Companies” by Fortune Magazine, and one of the “Great Place to Work in Healthcare” by Becker’s Hospital Review. Among the many honors he has received, “Modern Healthcare” has for the past two years named Dr. Massingale among the “50 Most Influential Physician Executives and Leaders”.
Nathan Every, MD
A cardiologist by training, Dr. Every has been with Frazier Healthcare Partners since 1999. He has led or co-led exited investments including Biostent (acquired by Abbott), Calibra Medical (acquired by LifeSpan), Rigel Pharmaceuticals (NASDAQ: RIGL), Flowcardia (acquired by C.R. Bard), BARRX, (acquired by Covidien), Ascension Orthopedics (acquired by Integra Lifesciences), Zeltiq (NASDAQ: ZLTQ), Glaukos (NASDAQ: GKOS), Packaging Coordinators Inc. (acquired by The Partners Group) and Abode Healthcare (acquired by Tailwind Capital). He currently serves on the boards of Correct Care Solutions, United Derm Partners, Silvergate Pharma, PCI, Leiter’s Compounding Pharmacy, The CORE Institute, and Vein Clinics of America. He also serves on the PRI Investment Committee for the Bill and Melinda Gates Foundation.
Norman Payson, MD
Dr. Payson has had a thirty-five year career as Chief Executive Officer and/or Chairman of multiple healthcare organizations including publicly traded and private equity sponsored companies. He is well known for his expertise in the “payor-provider” divide having led both payors and providers with expertise in arrangements between them and associated healthcare quality and cost outcomes. He is also an active participant in healthcare philanthropy and graduate education.